3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Gynecologic
1
Breast
1
Conditions
Ovarian Neoplasms
675
Breast Neoplasms
265
Uterine Cervical Neoplasms
240
Carcinoma, Non-Small-Cell Lung
218
Endometrial Neoplasms
201
Fallopian Tube Neoplasms
187
Carcinoma, Ovarian Epithelial
175
Colorectal Neoplasms
164
Stomach Neoplasms
152
Pancreatic Neoplasms
144
Neoplasms
143
Melanoma
118
Lung Neoplasms
112
Carcinoma, Renal Cell
111
Triple Negative Breast Neoplasms
108
Prostatic Neoplasms
108
Squamous Cell Carcinoma of Head and Neck
98
Neoplasm Metastasis
96
Esophageal Neoplasms
90
Urinary Bladder Neoplasms
85
Head and Neck Neoplasms
83
Sarcoma
69
Small Cell Lung Carcinoma
64
Carcinoma, Hepatocellular
64
Colonic Neoplasms
56
Carcinoma, Transitional Cell
49
Kidney Neoplasms
41
Testicular Neoplasms
38
Peritoneal Neoplasms
37
Anus Neoplasms
34
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Pancreatic Intraductal Neoplasms
×
Gynecologic
×
Clear all
NCT07213791
2026-06-04
FiREBOLT
Eli Lilly and Company
Phase 1
Recruiting
241 enrolled